Carregant...
Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario
BACKGROUND: High-dose chemotherapy with autologous stem-cell transplantation (asct) is an accepted part of standard therapy for patients with hematologic malignancies. Usually, stem-cell mobilization uses granulocyte colony–stimulating factor (g-csf); however, some patients are not able to be mobili...
Guardat en:
| Publicat a: | Curr Oncol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Multimed Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4974047/ https://ncbi.nlm.nih.gov/pubmed/27536190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3137 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|